• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Ronald W. Takvorian, M.D.


  • Soumerai JD, Hellmann MD, Feng Y, Sohani AR, Toomey CE, Barnes JA, Takvorian RW, Neuberg D, Hochberg EP, Abramson JS.Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease.Leuk Lymphoma. 2014 Mar;55(3):538-43.
  • Abramson JS, Takvorian RW, Fisher DC, Feng Y, Jacobsen ED, Brown JR, Barnes JA, Neuberg DS, Hochberg EP.Oral clofarabine for relapsed/refractory non-Hodgkin lymphomas: results of a phase 1 study.Leuk Lymphoma. 2013 Jan 30.
  • Amrein PC, Attar EC, Takvorian RW, Hochberg EP, Ballen KK, Leahy KM, Fisher DE, Lacasce AS, Jacobsen ED, Armand P, Hasserjian RP, Werner L, Neuberg DS, Brown JR.Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.Clin Cancer Res. 2011 Mar 14.
  • Straus DJ, Johnson JL, Lacasce AS, Bartlett NL, Kostakoglu L, Hsi ED, Schöder H, Hall NC, Jung SH, Canellos GP, Schwartz LH, Takvorian RW, Juweid ME, Cheson BD.Doxorubicin, vinblastine, gemcitabine (CALGB 50203) for stage I/II non-bulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.Blood. 2011 Feb 25.
  • Farkash EA, Ferry JA, Harris NL, Hochberg EP, Takvorian RW, Zuckerman DS, Sohani AR.Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls.J Hematop. 2009;2(4):237-44.
  • Brown JR,Friedberg JW,Feng Y,Scofield S,Phillips K,Dal Cin P,Joyce R,Takvorian RW,Fisher DC,Fisher RI,Liesveld J,Marquis D,Neuberg D,Freedman AS.A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.British Journal of Haematology. 2009 Jun;145(6):741-8.
  • Brown JR, Gaudet G, Friedberg JW, Neuberg D, Mauch P, Kutok JL, Takvorian T, Fisher DC, Gribben JG, Kim H, Nadler LM, Freedman AS.Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma.Leuk Lymphoma. 2004 Feb;45(2):315-20.
  • Friedberg JW, Fischman A, Neuberg D, Kim H, Takvorian T, Ng AK, Mauch PM, Canellos GP, van den Abbeele AD.FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison.Leuk Lymphoma. 2004 Jan;45(1):85-92.
  • Friedberg JW, Dong DA, Li S, Kim H, Stephans K, Noonan K, Neuberg D, Gribben JG, Fisher DC, Freedman AS, Takvorian T, Jurgens R, Battle TE, Frank DA.Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo.Leuk Res. 2004 Feb;28(2):139-47.
  • Friedberg JW, Neuberg D, Kim H, Miyata S, McCauley M, Fisher DC, Takvorian T, Canellos GP.Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease: unacceptable acute pulmonary toxicity.Cancer. 2003 Sep 1;98(5):978-82.
  • Backstrand KH, Ng AK, Takvorian RW, Jones EL, Fisher DC, Molnar-Griffin BJ, Silver B, Tarbell NJ, Mauch PM.Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease.J Clin Oncol. 2001 Feb 1;19(3):736-41.
  • Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC, Schlossman R, Alyea EP, Takvorian T, Jallow H, Kuhlman C, Ritz J, Nadler LM, Gribben JG.Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.Blood. 1999 Nov 15;94(10):3325-33.
  • Friedberg JW, Neuberg D, Gribben JG, Mauch P, Anderson KC, Soiffer RJ, Takvorian T, Fisher DC, Schlossman R, Jallow H, Kuhlman C, Ritz J, Freedman AS.Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.Biol Blood Marrow Transplant. 1999;5(4):262-8.
  • Soiffer RJ, Murray C, Mauch P, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Robertson MJ, Spector N, Gonin R.Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.J Clin Oncol. 1992 Jul;10(7):1191-200.
  • Freedman AS, Ritz J, Neuberg D, Anderson KC, Rabinowe SN, Mauch P, Takvorian T, Soiffer R, Blake K, Yeap B.Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma.Blood. 1991 Jun 1;77(11):2524-9.
  • Rabinowe SN, Soiffer RJ, Tarbell NJ, Neuberg D, Freedman AS, Seifter J, Blake KW, Gribben JG, Anderson KC, Takvorian T.Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies.Blood. 1991 Apr 15;77(8):1837-44.
  • Lew MA, Kehoe K, Ritz J, Antman KH, Nadler L, Takvorian T, Mayer R, Kalish L, Finberg R.Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.Transplantation. 1991 Mar;51(3):630-6.
  • Anderson KC, Barut BA, Ritz J, Freedman AS, Takvorian T, Rabinowe SN, Soiffer R, Heflin L, Coral F, Dear K.Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma.Blood. 1991 Feb 15;77(4):712-20.
  • Soiffer RJ, Mauch P, Tarbell NJ, Anderson KC, Freedman AS, Rabinowe SN, Takvorian T, Murrey CI, Coral F, Bosserman L.Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.Bone Marrow Transplant. 1991 Jan;7(1):23-33.
  • Kaplan WD, Jochelson MS, Herman TS, Nadler LM, Stomper PC, Takvorian T, Andersen JW, Canellos GP.Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.J Clin Oncol. 1990 Dec;8(12):1966-70.
  • Ayash LJ, Hunt M, Antman K, Nadler L, Wheeler C, Takvorian T, Elias A, Antin JH, Greenough T, Eder JP.Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas.J Clin Oncol. 1990 Oct;8(10):1699-706.
  • Anderson KC, Soiffer R, DeLage R, Takvorian T, Freedman AS, Rabinowe SL, Nadler LM, Dear K, Heflin L, Mauch P.T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications.Blood. 1990 Jul 1;76(1):235-44.
  • Freedman AS, Takvorian T, Anderson KC, Mauch P, Rabinowe SN, Blake K, Yeap B, Soiffer R, Coral F, Heflin L.Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.J Clin Oncol. 1990 May;8(5):784-91.
  • Pedrazzini A, Freedman AS, Andersen J, Heflin L, Anderson K, Takvorian T, Canellos GP, Whitman J, Coral F, Ritz J.Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function.Blood. 1989 Nov 1;74(6):2203-11.
  • Bosserman LD, Murray C, Takvorian T, Anderson KC, Freedman AS, Fitzsimmons J, Coral F, Nadler LM, Schlossman SF, Ritz J.Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.Bone Marrow Transplant. 1989 May;4(3):239-45.
  • Freedman AS, Takvorian T, Nadler LM, Anderson KC, Sallan SE, Ritz J.Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.Cancer Treat Res. 1988;38:265-83.